JP Morgan Chase’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-339,400
| Closed | -$28.8M | – | 5981 |
|
|
2019
Q4 | $28.8M | Buy |
339,400
+171,900
| +103% | +$11.5M | 0.01% | 1305 |
|
|
2019
Q3 | $8.38M | Sell |
167,500
-95,000
| -36% | -$3.79M | ﹤0.01% | 2272 |
|
|
2019
Q2 | $9.34M | Hold |
262,500
| – | – | ﹤0.01% | 2156 |
|
|
2019
Q1 | $7.34M | Buy |
262,500
+185,500
| +241% | +$4.37M | ﹤0.01% | 2299 |
|
|
2018
Q4 | $1.47M | Hold |
77,000
| – | – | ﹤0.01% | 3495 |
|
|
2018
Q3 | $2.3M | Buy |
77,000
+4,000
| +5% | +$151K | ﹤0.01% | 3360 |
|
|
2018
Q2 | $2.68M | Hold |
73,000
| – | – | ﹤0.01% | 3174 |
|
|
2018
Q1 | $2.4M | Sell |
73,000
-614,000
| -89% | -$19.2M | ﹤0.01% | 3134 |
|
|
2017
Q4 | $18.8M | Buy |
+687,000
| New | +$21.2M | ﹤0.01% | 1616 |
|
|
2017
Q3 | – | Sell |
-37,100
| Closed | -$1.41M | – | 5312 |
|
|
2017
Q2 | $1.41M | Buy |
37,100
+29,000
| +358% | +$1.29M | ﹤0.01% | 3249 |
|
|
2017
Q1 | $396K | Sell |
8,100
-9,500
| -54% | -$433K | ﹤0.01% | 3808 |
|
|
2016
Q4 | $597K | Sell |
17,600
-29,200
| -62% | -$1.04M | ﹤0.01% | 3676 |
|
|
2016
Q3 | $1.77M | Sell |
46,800
-10,000
| -18% | -$377K | ﹤0.01% | 2863 |
|
|
2016
Q2 | $1.91M | Buy |
56,800
+26,200
| +86% | +$924K | ﹤0.01% | 2833 |
|
|
2016
Q1 | $972K | Buy |
+30,600
| New | +$999K | ﹤0.01% | 3082 |
|
|
2015
Q1 | – | Sell |
-70,000
| Closed | -$1.94M | – | 4367 |
|
|
2014
Q4 | $1.94M | Hold |
70,000
| – | – | ﹤0.01% | 2982 |
|
|
2014
Q3 | $1.56M | Buy |
+70,000
| New | +$1.78M | ﹤0.01% | 3079 |
|
Other funds holding MDCO
JP Morgan Chase's MDCO Position: Q1 2020 in Review
JP Morgan Chase sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 547,883 shares — an estimated $46.5M sold.
JP Morgan Chase first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $46.5M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- JP Morgan Chase reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- JP Morgan Chase sold 547,883 Medicines Co shares in Q1 2020, an estimated $46.5M.
- JP Morgan Chase first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- JP Morgan Chase's Medicines Co position peaked at $46.5M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.